In vitro characterization of the anti-human cytomegalovirus activity of PMEA (Adefovir)

Antiviral Research

Volumn 36, Issue 2, 1997, Pages 131-137

  Xiong, Xiaofeng ^a   Flores, Carmina ^a   Fuller, Michael D ^a   Mendel, Dirk B ^a   Mulato, Andrew S ^a   Moon, Keith ^a   Chen, Ming S ^a   Cherrington, Julie M ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

Adefovir; Antiviral; HCMV; PMEA

Indexed keywords

ADEFOVIR;

ANTIVIRAL ACTIVITY; ARTICLE; CYTOMEGALOVIRUS; DRUG ACTIVITY; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IN VITRO STUDY; PRIORITY JOURNAL;

ADENINE; ANTIVIRAL AGENTS; CELL LINE; CYTOMEGALOVIRUS; HELA CELLS; HUMANS; PHOSPHONIC ACIDS;

ANIMALIA; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0030728303     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(97)00050-8     Document Type: Article

References (33)

1. Alford, C.A., Britt, W.J., 1990. Cytomegalovirus. In: Fields, B.N., Knipe, D.M. (Eds.), Virology. Raven Press, New York, pp. 1981-2010.
2. Balzarini J., De Clercq E. 5-phosphoribosyl 1-pyrophosphate synthetase converts the acyclic nucleoside phosphonates 9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and 9-(2-hydroxy-2-phosphonylmethoxyethyl)adenine directly to their antivirally active diphosphate derivatives. J. Biol. Chem. 266:1991;8686-8689.
3. Balzarini J., Hao Z., Herdewijn P., Johns D., De Clercq E. Intracellular metabolism and mechanism of anti-retrovirus action of 9-(2-phosphonylmethoxy)adenine, a potent anti-human immunodeficiency virus compound. Proc. Natl. Acad. Sci. USA. 88:1991;1499-1503.
4. Barditch-Crovo P., Toole J., Hendrix C.W., Cundy K.C., Ebeling D., Jaffe H.S., Lietman P.S. Anti-human immunodeficiency virus (HIV) activity, safety and pharmacokinetics of adefovir dipivoxil (9-[2-(bis-pivaloyloxymethyl)-phosphonylmethoxyethyl]adenine) in HIV-infected patients. J. Infect. Dis. 176:1997;406-413.
5. Biron K.K., Stanat S.C., Sorrell J.B., Fyfe J.A., Keller P.M., Lambe C.U., Nelson D.J. Metabolic activation of the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc. Natl. Acad. Sci. USA. 82:1985;2473-2477.
6. Bischofberger N., Hitchcock M.J.M., Chen M.S., Barkhimer D.B., Cundy K.C., Kent K.M., Lacy S.A., Lee W.A., Li Z.-H., Mendel D.B., Smee D.F., Smith J.L. 1-[((S)-2-Hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo. Antimicrob. Agents Chemother. 38:1994;2387-2391.
7. Chen M.S., Suttman R.T., Wu J.C., Prisbe E.J. Metabolism of 4-azidothymidine: a compound with potent and selective activity against the human immunodeficiency virus. J. Biol. Chem. 267:1992;257-260.
8. Cherrington J.M., Allen S.J.W., Bischofberger N., Chen M.S. Kinetic interaction of the diphosphates of 9-(2-phosphonylmethoxyethyl)adenine and other anti-HIV active cogeners with HIV reverse transcriptase and human DNA polymerases α, β and γ Antivir. Chem. Chemother. 6:1995;217-221.
9. DeCastro L.M., Kern E.R., De Clercq E., Ghaffar A., Mayer E.P., Vogt P.E., Gangemi J.D. Phosphonylmethoxyalkyl purine and pyrimidine derivatives for treatment of opportunistic cytomegalovirus and herpes simplex virus infections in murine AIDS. Antivir. Res. 16:1991;101-114.
10. De Clercq E. Antiviral activity spectrum and target of action of different classes of nucleoside analogues. Nucleosides Nucleotides. 13:1994;1271-1295.
11. De Clercq E., Holy A., Rosenberg I., Sakuma T., Balzarini J., Maudgal P.C. A novel selective broad-spectrum anti-DNA virus agent. Nature (London). 323:1986;464-467.
12. De Clercq E., Sakuma T., Baba M., Pauwels R., Balzarini J., Rosenberg I., Holy A. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antivir. Res. 8:1987;261-272.
13. Deeks, S., Collier, A., Lalezari, J., Pavia, A., Rodrigue, D., Lawrence Drew, W., Toole, J., Jaffe, H.S., Mulato, A.S., Lamy, P.D., Li, W., Cherrington, J.M., Hellmann, N., Kahn, J., 1997. The safety and efficacy of adefovir dipivoxil, a novel anti-HIV therapy, in HIV infected adults. J. Infect. Dis. (in press).
14. Duke A.E., Smee D.F., Chernow M., Boehme R., Matthews T.R. In vitro and in vivo activities of phosphate derivatives of 9-(1,3-dihydroxy-2-propoxymethyl)guanine against cytomegaloviruses. Antivir. Res. 6:1986;299-308.
15. Foster S.A., Cerny J., Cheng Y.C. Herpes simplex virus-specified DNA polymerase is the target for the antiviral action of 9-(2-phosphonylmethoxyethyl)adenine. J. Biol. Chem. 266:1991;238-244.
16. Lurain N.S., Thompson K.D., Holmes E.W., Read G.S. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J. Virol. 66:1992;7146-7152.
17. Mar E.C., Chiou J.F., Cheng Y.C., Huang E.S. Inhibition of cellular DNA polymerase a and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. J. Virol. 53:1985;776-780.
18. Metzger C., Michel D., Schneider K., Luske A., Schlight H.J., Mertens T. Human cytomegalovirus UL97 kinase confers gancyclovir susceptibility to recombinant vaccinia virus. J. Virol. 68:1994;8423-8427.
19. Mulato A.S., Cherrington J.M., Chen M.S. Anti-HCMV activity of cidofovir in combination with antiviral compounds and immunosuppressive agents: in vitro analyses. Antivir. Chem. Chemother. 7:1996;203-208.
20. Neyts J., Stals F., Bruggeman C., De Clercq E. Activity of the anti-HIV agent 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine against cytomegalovirus in vitro and in vivo. Eur. J. Clin. Microbiol. Infect. Dis. 12:1993;437-446.
21. Pauwels R., Balzarini J., Schols D., Baba M., Desmyter J., Rosenberg I., Holy A., De Clercq E. Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency agents. Antimicrob. Agents Chemother. 32:1988;1025-1030.
22. Prichard, M.N., Aseltine, K.R., Shipman, Jr., C., 1993. MacSynergy II, version 1 University of Michigan, Ann Arbor, Michigan, USA.
23. Reid R., Mar E.-C., Huang E.-S., Topal M.D. Insertion and extension of acyclic, dideoxy, and ara nucleotides by herpesviridae, human α and β polymerases. J. Biol. Chem. 263:1988;3898-3904.
24. Robbins B.L., Greenhaw J., Connelly M.C., Fridland A. Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)-adenine in human lymphoid cells. Antimicrob. Agents Chemother. 39:1995;2304-2308.
25. Smee D.F., Boehme R., Chernow M., Binko B.P., Matthews T.R. Intracellular metabolism and enzymatic phosphorylation of 9-(1,3-dihydroxy-2-propoxymethyl)guanine and acyclovir in herpes simplex virus-infected and uninfected cells. Biochem. Pharmacol. 34:1985;1049-1056.
26. Smith I.L., Cherrington J.M., Jiles R.E., Fuller M.D., Freeman W.R., Spector S.A. High level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and polymerase genes. J. Infect. Dis. 176:1997;69-77.
27. Snoeck R., Andrei G., De Clercq E. Patterns of resistance and sensitivity to antiviral compounds of drug resistant strains of human cytomegalovirus selected in vitro. Eur. J. Clin. Microbiol. Infect. Dis. 15:1996;574-579.
28. Srinivas R.V., Connely M., Fridland A. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes. Antivir. Res. 35:1997;23-27.
29. St. Clair M.H., Miller W.H., Miller R.L., Lambe C.U., Furman P.A. Inhibition of cellular alpha DNA polymerase and herpes simplex virus-induced DNA polymerases by the triphosphate of BW759U. Antimicrob. Agents Chemother. 25:1984;191-194.
30. Sullivan V., Talarico C.L., Stanat S.C., Davis M., Coen D.M., Biron K.K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 358:1992;162-163.
31. Xiong X., Chen M.S. Kinetic and mechanistic studies of the interaction of ganciclovir triphosphate with human DNA polymerases α, β, γ and human cytomegalovirus DNA polymerase. Antivir. Res. 30:1996;A109.
32. Xiong X., Smith J.L., Kim C., Huang E.-S., Chen M.S. Kinetic analysis of the interaction of cidofovir diphosphate with human cytomegalovirus DNA polymerase. Biochem. Pharmacol. 51:1996;1563-1567.
33. Xiong X., Smith J.L., Chen M.S. Effect of incorporation of cidofovir into DNA by human cytomegalovirus DNA polymerase on DNA elongation. Antimicrob. Agents Chemother. 41:1997;594-599.